Sitagliptin Tablet
Product Images NDC 70710-1899

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin (NDC 70710-1899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E6912c3b B985 4107 8093 82654bc1a3bb 01)

Image (E6912c3b B985 4107 8093 82654bc1a3bb 01)
Chemical structure of sitagliptin, showing its molecular arrangement with rings and functional groups including trifluoromethyl and amino groups.*
FDA Label Image

Image (E6912c3b B985 4107 8093 82654bc1a3bb 02)

Image (E6912c3b B985 4107 8093 82654bc1a3bb 02)
A line graph depicting the LS mean change from baseline over 24 weeks, comparing multiple treatment groups including placebo, Metformin 1000 mg b.i.d., Metformin 500 mg b.i.d., Sitagliptin 100 mg q.d., and combinations of Sitagliptin 50 mg b.i.d. with Metformin 500 mg or 1000 mg b.i.d. The x-axis represents weeks, and the y-axis represents the LS mean change from baseline.*
FDA Label Image

Image (E6912c3b B985 4107 8093 82654bc1a3bb 03)

Image (E6912c3b B985 4107 8093 82654bc1a3bb 03)
A line graph showing least squares mean change from baseline over 52 weeks. The x-axis represents weeks from 0 to 52, and the y-axis shows LS mean change with values ranging from 0.0 to -1.5. Two data sets or groups are plotted with markers, depicting trends of decrease followed by a slight increase over time.*
FDA Label Image

25 mg Label (E6912c3b B985 4107 8093 82654bc1a3bb 04)

25 mg Label (E6912c3b B985 4107 8093 82654bc1a3bb 04)
Sitagliptin Tablets 25 mg oral tablets packaging label by Zydus Pharmaceuticals (USA) Inc. The label indicates 90 tablets per container with instructions to dispense the enclosed Medication Guide to each patient. It includes storage instructions, dosage strength (25 mg Sitagliptin), NDC 70710-1899-9, and manufacturer details for Zydus Lifesciences Ltd., India. The label includes child resistance and moisture protection warnings.*
FDA Label Image

50 mg Label (E6912c3b B985 4107 8093 82654bc1a3bb 05)

50 mg Label (E6912c3b B985 4107 8093 82654bc1a3bb 05)
Sitagliptin 50 mg tablets label for oral use by Zydus Pharmaceuticals (USA) Inc. The label shows the product name, strength (50 mg), instructions to dispense the medication guide, usage within 3 months of opening, and package size of 90 tablets. It includes storage information and manufacturer details, with an NDC of 70710-1900-9.*
FDA Label Image

100 mg Label (E6912c3b B985 4107 8093 82654bc1a3bb 06)

100 mg Label (E6912c3b B985 4107 8093 82654bc1a3bb 06)
Sitagliptin 100 mg tablets packaging label from Zydus Pharmaceuticals (USA) Inc. The label specifies 90 tablets in the container, oral dosage form, and highlights dispensation in the original container with use within 3 months of opening. It includes storage instructions and a medication guide dispensing note.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.